SEC Form 4 · accession 0001144204-18-041780
USANA HEALTH SCIENCES INC · USNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gull Global Ltd
10% Owner
Period of report
Jul 31, 2018
Accepted (ET)
Aug 2, 2018 · 8:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000896264
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 31, 2018 | S | 100,000 | $131.50 | D | 10,395,614 | D | |
| Common StockF2,F3 | Aug 1, 2018 | S | 15,111 | $127.24 | D | 10,380,503 | D | |
| Common StockF3,F4 | Aug 1, 2018 | S | 4,743 | $128.05 | D | 10,375,760 | D | |
| Common StockF3,F5 | Aug 1, 2018 | S | 1,200 | $129.21 | D | 10,374,560 | D | |
| Common StockF3,F6 | Aug 1, 2018 | S | 2,700 | $130.32 | D | 10,371,860 | D | |
| Common StockF3,F7 | Aug 1, 2018 | S | 1,500 | $131.09 | D | 10,370,360 | D | |
| Common StockF3,F8 | Aug 1, 2018 | S | 108 | $132.25 | D | 10,370,252 | D | |
| Common StockF3,F9 | Aug 2, 2018 | S | 500 | $127.68 | D | 10,369,752 | D | |
| Common StockF3,F10 | Aug 2, 2018 | S | 5,002 | $128.78 | D | 10,364,750 | D | |
| Common StockF3,F11 | Aug 2, 2018 | S | 5,215 | $129.94 | D | 10,359,535 | D | |
| Common StockF3,F12 | Aug 2, 2018 | S | 3,003 | $130.86 | D | 10,356,532 | D | |
| Common StockF3,F13 | Aug 2, 2018 | S | 918 | $131.43 | D | 10,355,614 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F10Weighted average price. Price range in multiple transactions was $128.30 to $129.25, inclusive.
- F11Weighted average price. Price range in multiple transactions was $129.30 to $130.25, inclusive.
- F12Weighted average price. Price range in multiple transactions was $130.30 to $131.20, inclusive.
- F13Weighted average price. Price range in multiple transactions was $131.30 to $131.55, inclusive.
- F2Weighted average price. Price range in multiple transactions was $126.70 to $127.65, inclusive.
- F3The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth.
- F4Weighted average price. Price range in multiple transactions was $127.70 to $128.65, inclusive.
- F5Weighted average price. Price range in multiple transactions was $128.80 to $129.75, inclusive.
- F6Weighted average price. Price range in multiple transactions was $129.80 to $130.75, inclusive.
- F7Weighted average price. Price range in multiple transactions was $130.80 to $131.75, inclusive.
- F8Weighted average price. Price range in multiple transactions was $132.25 to $132.30, inclusive.
- F9Weighted average price. Price range in multiple transactions was $127.30 to $128.25, inclusive.